Stent-induced hypersensitivity leading to refractory in-stent restenosis: a case report.

IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Journal of Medical Case Reports Pub Date : 2025-03-04 DOI:10.1186/s13256-025-05122-4
Menghuai Ma, Jiong Tang
{"title":"Stent-induced hypersensitivity leading to refractory in-stent restenosis: a case report.","authors":"Menghuai Ma, Jiong Tang","doi":"10.1186/s13256-025-05122-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Even in the era of new-generation drug-eluting stents, in-stent restenosis remains a common and challenging problem of percutaneous coronary intervention. Among the many factors that contribute to in-stent restenosis, stent-related hypersensitivity is relatively rare, but may be a significant trigger of chronic refractory in-stent restenosis. Nevertheless, it is difficult to diagnose and assess the stent-related hypersensitivity, and there is no standardized treatment strategy.</p><p><strong>Case presentation: </strong>We present the case of a 63-year-old Chinese female who experienced refractory in-stent restenosis following the successful implantation of platinum chromium everolimus-eluting stents in the left main, left anterior descending and left circumflex artery. Although the cardiovascular risk factors were well-controlled, the patient developed four episodes of acute myocardial infarction with in-stent restenosis within 1 year. Intravascular ultrasound revealed diffuse neointimal hyperplasia in the in-stent restenosis lesion, and the blood tests showed no sign of systemic inflammation or infection. Thus, we speculated that the cause of refractory in-stent restenosis was stent-mediated hypersensitivity. Initially, the in-stent restenosis was treated with paclitaxel-coated balloon angioplasty, and only mild neointimal hyperplasia was observed on intravascular ultrasound 3 months after paclitaxel-coated balloon angioplasty. However, the paclitaxel-coated balloon could not prevent in-stent restenosis recurrence, and she eventually underwent coronary artery bypass grafting. After over 2 years of follow-up, her cardiac function had significantly improved, and the bridging vessels remained patent, as confirmed by computed tomography angiography.</p><p><strong>Conclusion: </strong>When encountering refractory in-stent restenosis, physicians should consider the potential for stent-associated hypersensitivity. Since there may be difficulty in obtaining histopathological examination of restenotic vessels, intravascular imaging can be instrumental in detecting neointimal hyperplasia and diagnosing stent allergy. Coronary artery bypass grafting may be a reasonable treatment for patients with stent allergy; further clinical research is required to explore the optimal treatments.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"19 1","pages":"96"},"PeriodicalIF":0.9000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11881395/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13256-025-05122-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Even in the era of new-generation drug-eluting stents, in-stent restenosis remains a common and challenging problem of percutaneous coronary intervention. Among the many factors that contribute to in-stent restenosis, stent-related hypersensitivity is relatively rare, but may be a significant trigger of chronic refractory in-stent restenosis. Nevertheless, it is difficult to diagnose and assess the stent-related hypersensitivity, and there is no standardized treatment strategy.

Case presentation: We present the case of a 63-year-old Chinese female who experienced refractory in-stent restenosis following the successful implantation of platinum chromium everolimus-eluting stents in the left main, left anterior descending and left circumflex artery. Although the cardiovascular risk factors were well-controlled, the patient developed four episodes of acute myocardial infarction with in-stent restenosis within 1 year. Intravascular ultrasound revealed diffuse neointimal hyperplasia in the in-stent restenosis lesion, and the blood tests showed no sign of systemic inflammation or infection. Thus, we speculated that the cause of refractory in-stent restenosis was stent-mediated hypersensitivity. Initially, the in-stent restenosis was treated with paclitaxel-coated balloon angioplasty, and only mild neointimal hyperplasia was observed on intravascular ultrasound 3 months after paclitaxel-coated balloon angioplasty. However, the paclitaxel-coated balloon could not prevent in-stent restenosis recurrence, and she eventually underwent coronary artery bypass grafting. After over 2 years of follow-up, her cardiac function had significantly improved, and the bridging vessels remained patent, as confirmed by computed tomography angiography.

Conclusion: When encountering refractory in-stent restenosis, physicians should consider the potential for stent-associated hypersensitivity. Since there may be difficulty in obtaining histopathological examination of restenotic vessels, intravascular imaging can be instrumental in detecting neointimal hyperplasia and diagnosing stent allergy. Coronary artery bypass grafting may be a reasonable treatment for patients with stent allergy; further clinical research is required to explore the optimal treatments.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Medical Case Reports
Journal of Medical Case Reports Medicine-Medicine (all)
CiteScore
1.50
自引率
0.00%
发文量
436
期刊介绍: JMCR is an open access, peer-reviewed online journal that will consider any original case report that expands the field of general medical knowledge. Reports should show one of the following: 1. Unreported or unusual side effects or adverse interactions involving medications 2. Unexpected or unusual presentations of a disease 3. New associations or variations in disease processes 4. Presentations, diagnoses and/or management of new and emerging diseases 5. An unexpected association between diseases or symptoms 6. An unexpected event in the course of observing or treating a patient 7. Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
期刊最新文献
Eosinophilic esophagitis manifesting as intractable hiccups in an elderly patient: a case report. Combined morphological and molecular approaches to the clinical diagnosis of Necator americanus infection: a case report. Identification of two previously unreported Duchenne muscular dystrophy gene variants in a patient diagnosed with a dystrophinopathy: a case report. The novel SERPINC1 missense mutation c.1148 T > A (p.L383H) causes hereditary antithrombin deficiency and thromboembolism in a Chinese family: a case report. Acute pancreatitis as an initial presentation of systemic lupus erythematosus: a case report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1